Pesquisa de referências

McKinsey on risk : new risk challenges and enduring themes for the return

Recurso electrónico / Electronic resource
Registro MARC
Tag12Valor
LDR  00000cam a22000004b 4500
001  MAP20210008153
003  MAP
005  20210315185250.0
008  180511e20210101usa|||| ||| ||eng d
040  ‎$a‎MAP‎$b‎spa‎$d‎MAP
084  ‎$a‎922.1
24514‎$a‎McKinsey on risk‎$b‎: new risk challenges and enduring themes for the return
260  ‎$a‎New York‎$b‎McKinsey & Company‎$c‎2021
300  ‎$a‎116 p.
520  ‎$a‎The tenth issue of McKinsey on Risk arrives as spirits, battered by public-health and economic hardships, have been lifted by the appearance of COVID-19 vaccines. Vaccines are beginning to reach priority and vulnerable populations, such as healthcare workers and long-term care residents. Governments and institutions are promising ever-wider distribution in the months ahead. Serious questions remain about production timelines and the completeness of vaccine delivery. For most economies, epidemiological uncertainty is the main factor complicating the conditions of return. Yet nations, sectors, companies, and individuals have endured different challenges and will travel different recovery paths, depending on the damage done.
650 4‎$0‎MAPA20080591182‎$a‎Gerencia de riesgos
650 4‎$0‎MAPA20100017982‎$a‎Riesgos emergentes
650 4‎$0‎MAPA20080662257‎$a‎Interrupción de negocio
650 4‎$0‎MAPA20140016556‎$a‎Resiliencia
650 4‎$0‎MAPA20080612429‎$a‎Riesgos extraordinarios
7102 ‎$0‎MAPA20080442569‎$a‎McKinsey & Company